CLDN3 and cancer: Because mouse claudin-3 is a high-affinity CpE receptor and human claudin-3 is a moderate-affinity receptor, results from mouse models of claudin-3-expressing cancers may appear more specific and, thus, cannot be used directly to predict outcomes in humans.